156 related articles for article (PubMed ID: 33819418)
1. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate.
Emecen Sanli M; Kilic A; Aktasoglu E; Inci A; Okur I; Ezgu F; Tumer L
J Pediatr Endocrinol Metab; 2021 Jun; 34(6):813-816. PubMed ID: 33819418
[TBL] [Abstract][Full Text] [Related]
2. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.
Finer G; Price HE; Shore RM; White KE; Langman CB
Am J Med Genet A; 2014 Jun; 164A(6):1545-9. PubMed ID: 24668887
[TBL] [Abstract][Full Text] [Related]
3. Topical Sodium Thiosulfate: A Treatment for Calcifications in Hyperphosphatemic Familial Tumoral Calcinosis?
Jost J; Bahans C; Courbebaisse M; Tran TA; Linglart A; Benistan K; Lienhardt A; Mutar H; Pfender E; Ratsimbazafy V; Guigonis V
J Clin Endocrinol Metab; 2016 Jul; 101(7):2810-5. PubMed ID: 27163355
[TBL] [Abstract][Full Text] [Related]
4. The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in
Döneray H; Özden A; Gürbüz K
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):239-243. PubMed ID: 33685073
[TBL] [Abstract][Full Text] [Related]
5. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
Lammoglia JJ; Mericq V
Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic success of sodium thiosulfate in treating cutaneous calciphylaxis in a patient with hyperphosphataemic familial tumoral calcinosis.
Requena S; Santos-Juanes J; Morales P; Gómez C
Australas J Dermatol; 2022 Feb; 63(1):e75-e77. PubMed ID: 34817065
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases.
Goossens J; Courbebaisse M; Caudron E; Bahans C; Vacquerie V; Melchior J; Salle PV; Moesch C; Daudon M; Frocht V; Richette P; Ea HK; Guigonis V
Semin Arthritis Rheum; 2017 Dec; 47(3):451-455. PubMed ID: 28779847
[TBL] [Abstract][Full Text] [Related]
8. Hyperphosphatemic tumoural calcinosis.
Shetty S; Kapoor N; Mathai S; Paul TV
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26811414
[No Abstract] [Full Text] [Related]
9. Dramatic diminution of a large calcification treated with topical sodium thiosulfate.
Ratsimbazafy V; Bahans C; Guigonis V
Arthritis Rheum; 2012 Nov; 64(11):3826. PubMed ID: 22806424
[No Abstract] [Full Text] [Related]
10. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi M; Fukagawa M
Clin Calcium; 2010 Nov; 20(11):1700-8. PubMed ID: 21037391
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Bilateral Lower Motor Neuron Type of Facial Palsy with Hearing Impairment: Hyperphosphatemic Familial Tumoral Calcinosis.
Gowda VK; Raj A; Vamyanmane DK; Nagarajappa VH; Srinivas SM; Tirumale R; Ranganath J; Gaddehosur C; Vishwanathan GB
J Pediatr Genet; 2023 Dec; 12(4):280-287. PubMed ID: 38162162
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?
Claramunt-Taberner D; Bertholet-Thomas A; Carlier MC; Dijoud F; Chotel F; Silve C; Bacchetta J
Pediatr Nephrol; 2018 Jul; 33(7):1263-1267. PubMed ID: 29594503
[TBL] [Abstract][Full Text] [Related]
13. Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.
Otukesh H; Hoseini R; Chalian H; Chalian M; Safarzadeh AE; Shakiba M; Poorian A
Pediatr Nephrol; 2007 Aug; 22(8):1235-7. PubMed ID: 17437133
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide.
Yamaguchi T; Sugimoto T; Imai Y; Fukase M; Fujita T; Chihara K
Bone; 1995 Apr; 16(4 Suppl):247S-250S. PubMed ID: 7626311
[TBL] [Abstract][Full Text] [Related]
15. Intravenous sodium thiosulfate for treating tumoral calcinosis associated with systemic disorders: Report of four cases.
Mageau A; Guigonis V; Ratzimbasafy V; Bardin T; Richette P; Urena P; Ea HK
Joint Bone Spine; 2017 May; 84(3):341-344. PubMed ID: 27955821
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease.
Fathallah-Shaykh S; Drozdz D; Flynn J; Jenkins R; Wesseling-Perry K; Swartz SJ; Wong C; Accomando B; Cox GF; Warady BA
Pediatr Nephrol; 2018 Feb; 33(2):325-333. PubMed ID: 28900759
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management.
Boyce AM; Lee AE; Roszko KL; Gafni RI
Front Endocrinol (Lausanne); 2020; 11():293. PubMed ID: 32457699
[TBL] [Abstract][Full Text] [Related]
18. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
[TBL] [Abstract][Full Text] [Related]
19. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic Calcinosis Cutis Successfully Treated with Topical Sodium Thiosulfate.
García-García E; López-López R; Álvarez-Del-Vayo C; Bernabeu-Wittel J
Pediatr Dermatol; 2017 May; 34(3):356-358. PubMed ID: 28382733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
